Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mirko Pinotti

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Venues

International journal of molecular sciences

Journal of thrombosis and haemostasis : JTH

Human mutation

RNA biology

Università degli Studi di Ferrara

Università degli Studi di Ferrara (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Ferrara

Italy

Associate Professor of Biochemistry :: Life Sciences and Biotechnology

Education History

Università degli Studi di Ferrara - Jun 28o 1998

Italy

PHD :: Dept. of Biochemistry and Molecular Biology

Publications

Laura Peretto, Elena Tonetto, Iva Maestri, Valentino Bezzerri, Roberto Valli, Marco Cipolli, Mirko Pinotti, Dario Balestra
Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing. International journal of molecular sciences 24 (4) (2023)
Laura Peretto, Elena Tonetto, Iva Maestri, Valentino Bezzerri, Roberto Valli, Marco Cipolli, Mirko Pinotti, Dario Balestra
Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing. International journal of molecular sciences 24 (4) (2023)
Laura Peretto, Elena Tonetto, Iva Maestri, Valentino Bezzerri, Roberto Valli, Marco Cipolli, Mirko Pinotti, Dario Balestra
Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing. International journal of molecular sciences 24 (4) (2023)
Barbara Lunghi, Nicole Ziliotto, Dario Balestra, Lucrezia Rossi, Patrizia Della Valle, Pasquale Pignatelli, Mirko Pinotti, Armando D'Angelo, Giovanna Marchetti, Francesco Bernardi
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction. International journal of molecular sciences 24 (18) (2023)
Laura Peretto, Elena Tonetto, Iva Maestri, Valentino Bezzerri, Roberto Valli, Marco Cipolli, Mirko Pinotti, Dario Balestra
Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing. International journal of molecular sciences 24 (4) (2023)
Laura Peretto, Elena Tonetto, Iva Maestri, Valentino Bezzerri, Roberto Valli, Marco Cipolli, Mirko Pinotti, Dario Balestra
Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing. International journal of molecular sciences 24 (4) (2023)
Angelisa Frasca, Efterpi Pavlidou, Matteo Bizzotto, Yunan Gao, Dario Balestra, Mirko Pinotti, Hans Atli Dahl, Nicholas D Mazarakis, Nicoletta Landsberger, Maria Kinali
Not Just Loss-of-Function Variations: Identification of a Hypermorphic Variant in a Patient With a CDKL5 Missense Substitution. Neurology. Genetics 8 (2) (2022)
Silvia Lombardi, Kristin Hovden Aaen, Jeannette Nilsen, Mattia Ferrarese, Torleif T Gjølberg, Francesco Bernardi, Mirko Pinotti, Jan Terje Andersen, Alessio Branchini
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity. British journal of haematology 194 (2) (2021)
Malin Bern, Jeannette Nilsen, Mattia Ferrarese, Kine M K Sand, Torleif T Gjølberg, Heidrun E Lode, Robert J Davidson, Rodney M Camire, Espen S Bækkevold, Stian Foss, Algirdas Grevys, Bjørn Dalhus, John Wilson, Lene Støkken Høydahl, Gregory J Christianson, Derry C Roopenian, Tilman Schlothauer, Terje E Michaelsen, Morten Carstens Moe, Silvia Lombardi, Mirko Pinotti, Inger Sandlie, Alessio Branchini, Jan Terje Andersen
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics. Science translational medicine 12 (565) (2021)
Alessio Branchini, Massimo Morfini, Barbara Lunghi, Donata Belvini, Paolo Radossi, Loredana Bury, Maria Luisa Serino, Paola Giordano, Dorina Cultrera, Angelo Claudio Molinari, Mariasanta Napolitano, Elisabetta Bigagli, Giancarlo Castaman, Mirko Pinotti, Francesco Bernardi, null null
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes. Journal of thrombosis and haemostasis : JTH (2021)
Matteo Campioni, Paulette Legendre, Cécile Loubiere, Barbara Lunghi, Mirko Pinotti, Olivier D Christophe, Peter J Lenting, Cecile V Denis, Francesco Bernardi, Caterina Casari
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A. Journal of thrombosis and haemostasis : JTH 19 (1) (2020)
Dario Balestra, Daniela Scalet, Mattia Ferrarese, Silvia Lombardi, Nicole Ziliotto, Chrystal C Croes, Naomi Petersen, Piter Bosma, Federico Riccardi, Franco Pagani, Mirko Pinotti, Stan F J van de Graaf
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I. International journal of molecular sciences 21 (6) (2020)
Dario Balestra, Mattia Ferrarese, Silvia Lombardi, Nicole Ziliotto, Alessio Branchini, Naomi Petersen, Piter Bosma, Mirko Pinotti, Stan F J van de Graaf
An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective spf/ash Mouse Model of Ornithine Transcarbamylase Deficiency. International journal of molecular sciences 21 (22) (2020)
Silvia Lombardi, Maria Francesca Testa, Mirko Pinotti, Alessio Branchini
Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. International journal of molecular sciences 21 (24) (2020)
Silvia Lombardi, Mattia Ferrarese, Saverio Marchi, Paolo Pinton, Mirko Pinotti, Francesco Bernardi, Alessio Branchini
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants. RNA biology 17 (2) (2019)
Daniela Scalet, Iva Maestri, Alessio Branchini, Francesco Bernardi, Mirko Pinotti, Dario Balestra
Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAs. Human mutation 40 (1) (2018)

Mirko Pinotti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mirko Pinotti